Andrew G. Hadley

1.4k total citations
42 papers, 962 citations indexed

About

Andrew G. Hadley is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Andrew G. Hadley has authored 42 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 16 papers in Genetics and 15 papers in Physiology. Recurrent topics in Andrew G. Hadley's work include Blood groups and transfusion (28 papers), Erythrocyte Function and Pathophysiology (15 papers) and Blood disorders and treatments (15 papers). Andrew G. Hadley is often cited by papers focused on Blood groups and transfusion (28 papers), Erythrocyte Function and Pathophysiology (15 papers) and Blood disorders and treatments (15 papers). Andrew G. Hadley collaborates with scholars based in United Kingdom, China and Nigeria. Andrew G. Hadley's co-authors include Belinda M. Kumpel, Lorna M. Williamson, Kathryn L. Armour, Mike Clark, G. D. Poole, G.A.W. Rook, Anthony H. Merry, B Zupańska, Helen Griffiths and Helen L. Griffiths and has published in prestigious journals such as British Journal of Cancer, European Journal of Immunology and British Journal of Haematology.

In The Last Decade

Andrew G. Hadley

41 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew G. Hadley United Kingdom 20 573 362 300 290 270 42 962
Peter C. Ligthart Netherlands 18 661 1.2× 193 0.5× 205 0.7× 465 1.6× 205 0.8× 42 913
M.A.M. Overbeeke Netherlands 23 1.3k 2.2× 114 0.3× 152 0.5× 825 2.8× 112 0.4× 54 1.5k
Gregory R. Halverson United States 14 341 0.6× 38 0.1× 79 0.3× 382 1.3× 199 0.7× 32 626
Nicole H. Smith United States 13 518 0.9× 28 0.1× 107 0.4× 480 1.7× 78 0.3× 22 714
LA Wilcox United States 7 278 0.5× 49 0.1× 537 1.8× 125 0.4× 85 0.3× 10 677
Kenichi Ogasawara Japan 17 869 1.5× 24 0.1× 60 0.2× 580 2.0× 140 0.5× 61 1.0k
Sara J. Dawson United Kingdom 8 167 0.3× 41 0.1× 303 1.0× 100 0.3× 346 1.3× 9 883
Christina Bade‐Doeding Germany 19 109 0.2× 70 0.2× 514 1.7× 65 0.2× 126 0.5× 48 724
Henri Isliker Switzerland 11 154 0.3× 160 0.4× 222 0.7× 70 0.2× 142 0.5× 23 501
JW Schrader Canada 8 158 0.3× 69 0.2× 478 1.6× 128 0.4× 220 0.8× 17 782

Countries citing papers authored by Andrew G. Hadley

Since Specialization
Citations

This map shows the geographic impact of Andrew G. Hadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew G. Hadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew G. Hadley more than expected).

Fields of papers citing papers by Andrew G. Hadley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew G. Hadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew G. Hadley. The network helps show where Andrew G. Hadley may publish in the future.

Co-authorship network of co-authors of Andrew G. Hadley

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew G. Hadley. A scholar is included among the top collaborators of Andrew G. Hadley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew G. Hadley. Andrew G. Hadley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hadley, Andrew G. & A. M. Holburn. (2008). The detection of anti-granulocyte antibodies by chemiluminescence. Clinical & Laboratory Haematology. 6(4). 351–361. 3 indexed citations
2.
3.
Bhattacharya, Sohinee, et al.. (2002). Outcome of consecutive pregnancies in a patient with Bombay (Oh) blood group. Transfusion Medicine. 12(6). 379–382. 11 indexed citations
4.
Hadley, Andrew G.. (2002). Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn. Transplant Immunology. 10(2-3). 191–198. 28 indexed citations
5.
Armour, Kathryn L., Mike Clark, Andrew G. Hadley, & Lorna M. Williamson. (1999). Recombinant human IgG molecules lacking Fcγ receptor I binding and monocyte triggering activities. European Journal of Immunology. 29(8). 2613–2624. 152 indexed citations
6.
Hadley, Andrew G.. (1998). A Comparison of in Vitro Tests for predicting the Severity of Haemolytic Disease of the Fetus and Newborn. Vox Sanguinis. 74(S2). 375–383. 23 indexed citations
7.
Hadley, Andrew G., et al.. (1998). The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn. BJOG An International Journal of Obstetrics & Gynaecology. 105(2). 231–234. 23 indexed citations
8.
9.
Hadley, Andrew G., et al.. (1996). Haemolytic Disease of the Newborn Due to Anti‐G. Vox Sanguinis. 71(2). 108–112. 28 indexed citations
10.
Filbey, Derek, et al.. (1996). Quantitative and functional assessment of anti‐RhD: a comparative study of non‐invasive methods in antenatal prediction of Rh hemolytic disease. Acta Obstetricia Et Gynecologica Scandinavica. 75(2). 102–107. 7 indexed citations
11.
Hadley, Andrew G., B Zupańska, Belinda M. Kumpel, et al.. (1995). The glycosylation of red cell autoantibodies affects their functional activity in vitro. British Journal of Haematology. 91(3). 587–594. 17 indexed citations
12.
Poole, G. D., et al.. (1995). Predicting the severity of haemolytic disease of the newborn: an assessment of the clinical usefulness of the chemiluminescence test. British Journal of Haematology. 90(3). 718–720. 6 indexed citations
13.
Bakács, Tibor, Andrew G. Hadley, Belinda M. Kumpel, David M. Segal, & Ferenc Bánhidy. (1994). Comparison of the ability of red cells sensitized with a bispecific anti-D × anti-FcγRIII Fab fragment to activate human K cells and peritoneal macrophages through FcγRIII. Immunology Letters. 42(1-2). 91–95. 1 indexed citations
14.
Lucas, G., Andrew G. Hadley, Sandra J. Nance, & George Garratty. (1993). Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion. 33(6). 484–487. 29 indexed citations
15.
Kumpel, Belinda M., et al.. (1991). Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells.. PubMed. 72(4). 481–5. 26 indexed citations
16.
Hadley, Andrew G., et al.. (1991). Correlation of serological, quantitative and cell‐mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn. British Journal of Haematology. 77(2). 221–228. 48 indexed citations
17.
Hadley, Andrew G. & Belinda M. Kumpel. (1989). Phagocytosis by Human Monocytes of Red Cells Sensitized with Monoclonal IgG1 and IgG3 Anti‐D. Vox Sanguinis. 57(2). 150–151. 16 indexed citations
18.
Hadley, Andrew G., et al.. (1989). An in-vitro assessment of the functional activity of monoclonal anti-D. Clinical & Laboratory Haematology. 11(1). 47–54. 27 indexed citations
19.
Hadley, Andrew G., Belinda M. Kumpel, & Anthony H. Merry. (1988). The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies. Clinical & Laboratory Haematology. 10(4). 377–384. 37 indexed citations
20.
Hadley, Andrew G., M. Byron, H Chapel, C Bunch, & A. M. Holburn. (1987). Anti‐granulocyte opsonic activity in sera from patients with systemic lupus erythematosus. British Journal of Haematology. 65(1). 61–65. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter C. Ligthart Breakdown of academic impact, for papers by M.A.M. Overbeeke Breakdown of academic impact, for papers by Gregory R. Halverson Breakdown of academic impact, for papers by Nicole H. Smith Breakdown of academic impact, for papers by LA Wilcox Breakdown of academic impact, for papers by Kenichi Ogasawara Breakdown of academic impact, for papers by Sara J. Dawson Breakdown of academic impact, for papers by Christina Bade‐Doeding Breakdown of academic impact, for papers by Henri Isliker Breakdown of academic impact, for papers by JW Schrader
Rankless by CCL
2026